Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J M Ross

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Annales D'Endocrinologie|July 27, 2007
Doses and steroids to be used in primary and central hypoadrenalismM Debono, R J M Ross
Hormone Research|November 16, 2005
Timing and type of glucocorticoid replacement in adult congenital adrenal hyperplasiaR J M Ross, A Rostami-Hodjegan
Journal of Molecular Endocrinology|August 30, 2002
Pegvisomant: structure and functionS Pradhananga, I Wilkinson, R J M Ross
The Journal of Clinical Endocrinology and Metabolism|September 10, 2004
Pegvisomant, a growth hormone-specific antagonist, undergoes cellular internalizationM Maamra, J J Kopchick, C J Strasburger, et al.
Lancet (London, England)|July 5, 2003
Patients with chronic pain and abnormal pituitary function require investigationZ Merza, N Edwards, S J Walters, et al.
Clinical Endocrinology|October 1, 2008
Cross-sectional analysis of testosterone therapies in hypopituitary men on stable pituitary hormone replacementS Siyambalapitiya, P Jonsson, M Koltowska-Haggstrom, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|September 27, 2005
Hypopituitary patients prefer a touch-screen to paper quality of life questionnaireI M Goodhart, V Ibbotson, A Doane, et al.
The Journal of Clinical Endocrinology and Metabolism|August 11, 2005
Estrogen replacement in women of fertile years with hypopituitarismP M Mah, J Webster, P Jönsson, et al.
Bone Marrow Transplantation|April 9, 2014
Endocrine, metabolic, nutritional and body composition abnormalities are common in advanced intensively-treated (transplanted) multiple myelomaD M Greenfield, E Boland, Y Ezaydi, et al.
Clinical Endocrinology|September 7, 2007
Modified-release hydrocortisone for circadian therapy: a proof-of-principle study in dexamethasone-suppressed normal volunteersJ Newell-Price, M Whiteman, A Rostami-Hodjegan, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Annales D'Endocrinologie|July 27, 2007
Doses and steroids to be used in primary and central hypoadrenalismM Debono, R J M Ross
Hormone Research|November 16, 2005
Timing and type of glucocorticoid replacement in adult congenital adrenal hyperplasiaR J M Ross, A Rostami-Hodjegan
Journal of Molecular Endocrinology|August 30, 2002
Pegvisomant: structure and functionS Pradhananga, I Wilkinson, R J M Ross
The Journal of Clinical Endocrinology and Metabolism|September 10, 2004
Pegvisomant, a growth hormone-specific antagonist, undergoes cellular internalizationM Maamra, J J Kopchick, C J Strasburger, et al.
Lancet (London, England)|July 5, 2003
Patients with chronic pain and abnormal pituitary function require investigationZ Merza, N Edwards, S J Walters, et al.
Clinical Endocrinology|October 1, 2008
Cross-sectional analysis of testosterone therapies in hypopituitary men on stable pituitary hormone replacementS Siyambalapitiya, P Jonsson, M Koltowska-Haggstrom, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|September 27, 2005
Hypopituitary patients prefer a touch-screen to paper quality of life questionnaireI M Goodhart, V Ibbotson, A Doane, et al.
The Journal of Clinical Endocrinology and Metabolism|August 11, 2005
Estrogen replacement in women of fertile years with hypopituitarismP M Mah, J Webster, P Jönsson, et al.
Bone Marrow Transplantation|April 9, 2014
Endocrine, metabolic, nutritional and body composition abnormalities are common in advanced intensively-treated (transplanted) multiple myelomaD M Greenfield, E Boland, Y Ezaydi, et al.
Clinical Endocrinology|September 7, 2007
Modified-release hydrocortisone for circadian therapy: a proof-of-principle study in dexamethasone-suppressed normal volunteersJ Newell-Price, M Whiteman, A Rostami-Hodjegan, et al.
Pageof 2